Opeolu M. Adeoye, M.D., M.S., BJC HealthCare Distinguished Professor of Emergency Medicine, Chair of the Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri
Opeolu M. Adeoye, M.D., M.S., BJC HealthCare Distinguished Professor of Emergency Medicine, Chair of the Department of Emergency Medicine, Washington University School of Medicine, St. Louis, Missouri
Dr. Albert on ISC24 HUP20-101 ask your doc health questions
American Heart Association immediate past president, Michelle A. Albert, M.D., M.P.H., FAHA is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco, director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center) and associate dean of admissions at the University of California, San Francisco School of Medicine.
Dr. Albert on ISC24 HUP20-101 Black Women's Health study insight
American Heart Association immediate past president, Michelle A. Albert, M.D., M.P.H., FAHA is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco, director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center) and associate dean of admissions at the University of California, San Francisco School of Medicine.
Dr. Albert on ISC24 HUP20-101 critical warning signs
American Heart Association immediate past president, Michelle A. Albert, M.D., M.P.H., FAHA is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco, director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center) and associate dean of admissions at the University of California, San Francisco School of Medicine.
Dr. Albert on ISC24 HUP20-101 optimizing patient-doc communications
American Heart Association immediate past president, Michelle A. Albert, M.D., M.P.H., FAHA is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco, director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center) and associate dean of admissions at the University of California, San Francisco School of Medicine.
Dr. Albert on ISC24 HUP20-101 risk factor findings
American Heart Association immediate past president, Michelle A. Albert, M.D., M.P.H., FAHA is the Walter A. Haas-Lucie Stern Endowed Chair in Cardiology and professor of medicine at the University of California at San Francisco, director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center) and associate dean of admissions at the University of California, San Francisco School of Medicine.
Dr. Barreto on ISC24 LB3 MOST trial answered questions
Andrew D. Barreto, M.D., M.S., is an Associate Professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Dr. Barreto on ISC24 LB3 MOST trial efficacy-safety
Andrew D. Barreto, M.D., M.S., is an Associate Professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Andrew D. Barreto, M.D., M.S., is an Associate Professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth).
Jason Davies, M.D., Ph.D., an associate professor in the departments of neurosurgery and biomedical informatics at the State University of New York, Buffalo.
Dr. Davies on ISC24 LB 28 artery blocking treatment
Jason Davies, M.D., Ph.D., an associate professor in the departments of neurosurgery and biomedical informatics at the State University of New York, Buffalo.
Dr. Davies on ISC24 LB 28 exciting results of EMBOLISE study
Jason Davies, M.D., Ph.D., an associate professor in the departments of neurosurgery and biomedical informatics at the State University of New York, Buffalo.
Dr. Elkind on ISC24 WMP30 comparing alteplase-tenecteplase
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Dr. Elkind on ISC24 WMP30 CT scan and types of stroke
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Dr. Elkind on ISC24 WMP30 faster treatment impact outcomes
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Dr. Elkind on ISC24 WMP30 stroke warning signs-FAST
Mitchell S. V. Elkind, M.D., M.S., FAHA, chief clinical science officer of the American Heart Association, a past president of the American Heart Association, past chair of the Advisory Committee of the American Stroke Association — a division of the American Heart Association, and a tenured professor of neurology and epidemiology at Columbia University in New York.
Randi Foraker, Ph.D., M.A., FAHA, vice chair of the American Heart Association’s Epidemiology & Cardiovascular Stroke Nursing Prevention Science Committee, and professor of medicine, Institute for Informatics, Data Science and Biostatistics and director, Center for Population Health Informatics at Washington University in St. Louis, School of Medicine, Missouri.
Dr. Foraker on ISC24 WMP31 mental wellbeing and recovery
Randi Foraker, Ph.D., M.A., FAHA, vice chair of the American Heart Association’s Epidemiology & Cardiovascular Stroke Nursing Prevention Science Committee, and professor of medicine, Institute for Informatics, Data Science and Biostatistics and director, Center for Population Health Informatics at Washington University in St. Louis, School of Medicine, Missouri.
Randi Foraker, Ph.D., M.A., FAHA, vice chair of the American Heart Association’s Epidemiology & Cardiovascular Stroke Nursing Prevention Science Committee, and professor of medicine, Institute for Informatics, Data Science and Biostatistics and director, Center for Population Health Informatics at Washington University in St. Louis, School of Medicine, Missouri.
Randi Foraker, Ph.D., M.A., FAHA, vice chair of the American Heart Association’s Epidemiology & Cardiovascular Stroke Nursing Prevention Science Committee, and professor of medicine, Institute for Informatics, Data Science and Biostatistics and director, Center for Population Health Informatics at Washington University in St. Louis, School of Medicine, Missouri.
Dr. Foraker on ISC24 WMP31 watch for behavior changes
Randi Foraker, Ph.D., M.A., FAHA, vice chair of the American Heart Association’s Epidemiology & Cardiovascular Stroke Nursing Prevention Science Committee, and professor of medicine, Institute for Informatics, Data Science and Biostatistics and director, Center for Population Health Informatics at Washington University in St. Louis, School of Medicine, Missouri.
Elizabeth A. Jackson, M.D., M.P.H., FAHA, immediate past chair of the Association’s Committee on Social Determinants of Health and a professor and director of the Cardiovascular Outcomes and Effectiveness Research Program at the University of Alabama at Birmingham.
Dr. Jackson on ISC24 HUP3 care continuity after stroke
Elizabeth A. Jackson, M.D., M.P.H., FAHA, immediate past chair of the Association’s Committee on Social Determinants of Health and a professor and director of the Cardiovascular Outcomes and Effectiveness Research Program at the University of Alabama at Birmingham.
Elizabeth A. Jackson, M.D., M.P.H., FAHA, immediate past chair of the Association’s Committee on Social Determinants of Health and a professor and director of the Cardiovascular Outcomes and Effectiveness Research Program at the University of Alabama at Birmingham.
Dr. Jackson on ISC24 HUP3 SDOH and resource availability
Elizabeth A. Jackson, M.D., M.P.H., FAHA, immediate past chair of the Association’s Committee on Social Determinants of Health and a professor and director of the Cardiovascular Outcomes and Effectiveness Research Program at the University of Alabama at Birmingham.
Dr. Jackson on ISC24 HUP3 zip code and functional outcome impact
Elizabeth A. Jackson, M.D., M.P.H., FAHA, immediate past chair of the Association’s Committee on Social Determinants of Health and a professor and director of the Cardiovascular Outcomes and Effectiveness Research Program at the University of Alabama at Birmingham.
Dr. Lackland on ISC24 TMP26 communicating-addressing barriers
Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Dr. Lackland on ISC24 TMP26 physical activity critical
Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Dr. Lackland on ISC24 TMP26 safe environment availability
Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Dr. Lackland on ISC24 TMP26 study results perspective
Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Dr. Lackland on ISC24 TMP26 treatments consider access options
Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division of Translational Neurosciences and Population Studies in the department of neurology at the Medical University of South Carolina in Charleston.
Zixiao Li, M.D., Ph.D., chief physician, professor and deputy director of neurology at Capital Medical University’s Beijing Tiantan Hospital in Beijing, China.
Zixiao Li, M.D., Ph.D., chief physician, professor and deputy director of neurology at Capital Medical University’s Beijing Tiantan Hospital in Beijing, China.
Dr. Li on ISC24 LB15 quality of stroke care importance
Zixiao Li, M.D., Ph.D., chief physician, professor and deputy director of neurology at Capital Medical University’s Beijing Tiantan Hospital in Beijing, China.
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
Dr. Stein on ISC24 118 considering treatment options
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
Joel Stein, M.D., FAHA, chair of the writing group for the American Heart Association’s/American Stroke Association’s 2021 Clinical Performance Measures for Stroke Rehabilitation and the Simon Baruch Professor and chair of the department of rehabilitation and regenerative medicine at Columbia University’s Vagelos College of Physicians and Surgeons; professor and chair of the department of rehabilitation medicine at Weill Cornell Medicine; and physiatrist-in-chief at NewYork-Presbyterian Hospital.
